Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0358419940370050901
Korean Journal of Obstetrics and Gynecology
1994 Volume.37 No. 5 p.901 ~ p.906
Clinical Efficacy of Iron Protein Succinylate (Hemo-Q) in Pregnant Women
±èÈÖ
±èÁøÈ«/±èÂùÁÖ/¹Ú¹Ì¼÷/±èÀåÈí/±è¼öÆò
Abstract
Iron protein succinylate (Hemo-Q) is a new iron preparation for oral administration. Clinical efficacy and safety of iron protein succinylate were evaluated in 40 pregnancy and postpartum women under serum hemoglobulin level 10 gm/dl.
The aim of this study was to assess the efficacy and tolerability of iron protein succiny-late in iron deficiency anemia of pregnant and postpartum women.
Most women received 2 bottles(30 ml) every day for 60 days. Improvement was measured by hematologic variables and clinical symptom or sign after 30 days and 60 days respectively.
In Conclusion
1. Efficacy of iron protein succinylate showed significant difference among pretreatment, 30 and 60 days treatment group in serum hemoglobulin and iron level.
2. Improvement of clinical symptom (polypnea, asthenia, anorexia) and sign (cutaneous, mucous pallor) of iron deficiency anemia were noted in both 30 and 60 days treatment.
3. Side effects (vomiting, constipation. Diarrhea, gastric discomfort) were reported with 1 (2.5%) to 2 (5%) of 40 women.
KEYWORD
FullTexts / Linksout information
  
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø